Loading clinical trials...

Set Point Acupuncture for Migraines Using a Digital Assistant | Clinical Trials | Clareo Health

COMPLETEDPHASE1

Set Point Acupuncture for Migraines Using a Digital Assistant

NCT00714727•Memorial Medical Center

Summary

The object of this research study is to test a standardized set of acupuncture points on migraine patients to reduce frequency and intensity of headaches. Acupuncture has been studied in prior research but the treatment points have varied between subjects, making it difficult to replicate studies.

Detailed Description

Subjects will be recording daily headache activity on personal digital assistants (PDA's) for 12 weeks before and 12 weeks after 8 weeks of acupuncture intervention. MIDAS, HIT-6 and BDI-II measurements will be done at the beginning of the study (12 weeks pre-intervention), directly before the intervention, directly after, and 12 weeks post-intervention. Measurements will be compared before and after intervention. This is a follow-up to a successful earlier study when these same acupuncture points were used on subjects with chronic daily headache, the majority being migraine.

Eligibility

Age

21 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male and female subjects between the ages of 21 years and 65 years of age
•Subjects with a history of migraine headaches for at least 12 months
•Subjects who have not received acupuncture for any medical condition in the past 6 months.
•A negative pregnancy test for childbearing females since some acupuncture points may be contraindicated in pregnancy. Pregnancy tests will be conducted at MMC.
•Subjects willing and able to use a PDA daily for data collection

Exclusion Criteria

•Subjects who plan to receive acupuncture treatment for any other type of medical condition while enrolled in this protocol
•Subjects with the presence of organic pathology (i.e., brain tumor)
•Subjects who have the presence of a systemic disorder or illness, including serious psychiatric illness
•Subjects who began a new headache treatment less than two weeks before proposed enrollment date
•Subjects who are pregnant, lactating, or planning to become pregnant within 6 months
•Subjects that use alcohol on a regular basis
•Subjects that use recreational drugs
•Subjects that have a cardiac pacemaker
•Subjects that use analgesics on more than 10 days per month
•Subjects that exercise prophylactic headache treatment with drugs during the past 4 weeks

Locations (1)

John P Murtha Neuroscience and Pain Institute

Johnstown, Pennsylvania, United States

Key Dates

Start Date

July 1, 2008

Primary Completion Date

January 1, 2011

Completion Date

January 1, 2011

Last Updated

July 12, 2013

Enrollment

ACTUAL participants

Conditions

Migraine Headaches

Interventions

acupuncture

PROCEDURE

Craniosacral Therapy in Migraine: A Feasibility Study

NCT00665236

Migraine Headaches

View study

COMPLETEDPHASE3

To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches

NCT00433732

Migraine Headaches

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions